Bank Of America Corp Novo Cure LTD Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Novo Cure LTD stock. As of the latest transaction made, Bank Of America Corp holds 236,259 shares of NVCR stock, worth $4.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

236,259

Previous 78,668 200.32%

Holding current value

$4.3 Million

Previous $2.34 Million 79.61%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$17.82 - $30.19 $2.81 Million - $4.76 Million	157,591 Added 200.32%	236,259 $4.21 Million
Q4 2024 Feb 14, 2025	SELL	$14.54 - $33.41 $6.18 Million - $14.2 Million	-425,188 Reduced 84.39%	78,668 $2.34 Million
Q3 2024 Nov 14, 2024	SELL	$15.61 - $23.34 $745,845 - $1.12 Million	-47,780 Reduced 8.66%	503,856 $7.88 Million
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $8.32 Million - $16.9 Million	-703,495 Reduced 56.05%	551,636 $9.45 Million
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $7.16 Million - $9.97 Million	576,519 Added 84.96%	1,255,131 $19.6 Million
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $6.16 Million - $8.73 Million	553,197 Added 441.09%	678,612 $10.1 Million
Q2 2023 Aug 14, 2023	SELL	$40.29 - $82.51 $9.2 Million - $18.8 Million	-228,364 Reduced 64.55%	125,415 $5.2 Million
Q1 2023 May 12, 2023	BUY	$56.44 - $118.81 $9.91 Million - $20.9 Million	175,581 Added 98.53%	353,779 $21.3 Million
Q4 2022 Feb 10, 2023	SELL	$63.98 - $85.37 $4.05 Million - $5.4 Million	-63,260 Reduced 26.2%	178,198 $13.1 Million
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $4.93 Million - $6.5 Million	72,524 Added 42.93%	241,458 $18.3 Million
Q2 2022 Aug 12, 2022	SELL	$56.6 - $89.9 $1.74 Million - $2.76 Million	-30,660 Reduced 15.36%	168,934 $11.7 Million
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $660,567 - $928,198	-10,982 Reduced 5.22%	199,594 $16.5 Million
Q4 2021 Feb 08, 2022	SELL	$75.08 - $121.99 $1.66 Million - $2.7 Million	-22,164 Reduced 9.52%	210,576 $15.8 Million
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $8.02 Million - $13.4 Million	69,013 Added 42.15%	232,740 $27 Million
Q2 2021 Sep 13, 2021	BUY	$130.4 - $225.58 $21.4 Million - $36.9 Million	163,727 New	163,727 $36.3 Million

Others Institutions Holding NVCR

# of Institutions

265

Shares Held

79.4M

Call Options Held

970K

Put Options Held

118K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.91B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Novo Cure LTD Transaction History